Biotargets of Cancer in Current Clinical Practice
(Sprache: Englisch)
Here is a concise listing of major cancer types, with epidemiology, diagnostic biomarkers, descriptions of genes for prognosis and therapy through biotarget-specific molecular treatments. Covers current debate on patentability of genetic information and more.
Voraussichtlich lieferbar in 3 Tag(en)
versandkostenfrei
Buch (Kartoniert)
274.99 €
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
- Ratenzahlung möglich
Produktdetails
Produktinformationen zu „Biotargets of Cancer in Current Clinical Practice “
Here is a concise listing of major cancer types, with epidemiology, diagnostic biomarkers, descriptions of genes for prognosis and therapy through biotarget-specific molecular treatments. Covers current debate on patentability of genetic information and more.
Klappentext zu „Biotargets of Cancer in Current Clinical Practice “
Biotargets of Cancer in Current Clinical Practice presents an updated and reasoned review of the current status of knowledge concerning the major cancer types with a special focus on the current biomarkers, genes involved and the potential future targets of innovative therapies. The volume includes for each major cancer type, a comprehensive although concise discussion of epidemiology, affirmed and innovative biomarkers for diagnosis, and descriptions of the relevant genes for prognosis and (individualized) therapy through biotarget-specific new molecular treatments, with the latest information on the validation status of each novel biomarker. Individual chapters are dedicated to the major cancer types, plus a special chapter on metastasis. The present debate on patentability of genetic information applied to diagnostics and therapeutics of cancer is also discussed.
Inhaltsverzeichnis zu „Biotargets of Cancer in Current Clinical Practice “
Central Nervous System Tumors.- Head and Neck Tumors.- Thyroid Cancer.- Targeted Therapies for Non-Small Cell Lung Cancer.- Non-Hodgkin Lymphomas.- Leukemias.- Breast Cancer.- Esophago-Gastric Cancer.- Colorectal Cancer.- Hepatocellular Carcinoma.- Biomarkers for Prognosis and Molecularly Targeted Therapy in Renal Cell Carcinoma.- Bladder Cancer.- Biomarkers in Prostate cancer.- Ovarian Cancer.- Uterine Cancer: The Influence of Genetics and Environment on Cell Cycling Pathways in Cancer.- Biotargets in Sarcomas: The Past, Present and a Look into the Future.- Melanoma and other skin cancers.- Molecular pathology of cancer metastasis: suggestions for future therapy.- Current and future developments in cancer therapy research: miRNAs as new promising targets or tools.
Autoren-Porträt
Mauro Bologna, MDUniversity of L'Aquila, L'Aquila, Italy
Bibliographische Angaben
- 2016, Softcover reprint of the original 1st ed. 2012, XVI, 564 Seiten, Maße: 17,8 x 25,4 cm, Kartoniert (TB), Englisch
- Herausgegeben: Mauro Bologna
- Verlag: Springer, Berlin
- ISBN-10: 1493959468
- ISBN-13: 9781493959464
Sprache:
Englisch
Pressezitat
From the reviews:"In this book on clinically significant biotargets in cancer research, every organ system is thoroughly represented with adequate overviews and precise details of the biotargets. ... the book is intended specifically for clinicians in the field, including medical students, residents, pathologists, and oncologists. ... This is a well-written book that attempts to provide a wide spectrum of current scientific information about the clinical management of oncologic patients based on molecular aspects. ... this book achieves its objectives while remaining easy to read." (Natalie Webster, Doody's Review Service, October, 2012)
Kommentar zu "Biotargets of Cancer in Current Clinical Practice"
Schreiben Sie einen Kommentar zu "Biotargets of Cancer in Current Clinical Practice".
Kommentar verfassen